References
- Coates RJ, Weiss NS, Daling JR, Morris JS, Labbe RF. Serum levels of selenium and retinol and the subsequent risk of cancer. Am J Epidemiol. 1988;128(3):515–23. doi:https://doi.org/10.1093/oxfordjournals.aje.a114999
- Gann PH, Ma J, Giovannucci E, Willett W, Sacks FM, Hennekens CH, Stampfer MJ. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res. 1999;59(6):1225–30.
- Gill JK, Franke AA, Steven Morris J, Cooney RV, Wilkens LR, Le Marchand L, Goodman MT, Henderson BE, Kolonel LN. Association of selenium, tocopherols, carotenoids, retinol, and 15-isoprostane f(2t) in serum or urine with prostate cancer risk: The multiethnic cohort. Cancer Causes Control. 2009;20(7):1161–71. doi:https://doi.org/10.1007/s10552-009-9304-4
- Goodman GE, Schaffer S, Omenn GS, Chen C, King I. The association between lung and prostate cancer risk, and serum micronutrients: Results and lessons learned from beta-carotene and retinol efficacy trial. Cancer Epidemiol Biomarkers Prev. 2003;12(6):518–26.
- Hsing AW, Comstock GW, Abbey H, Polk BF. Serologic precursors of cancer. Retinol, carotenoids, and tocopherol and risk of prostate cancer. J Natl Cancer Inst. 1990;82(11):941–6. doi:https://doi.org/10.1093/jnci/82.11.941
- Huang HY, Alberg AJ, Norkus EP, Hoffman SC, Comstock GW, Helzlsouer KJ. Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer. Am J Epidemiol. 2003;157(4):335–44. doi:https://doi.org/10.1093/aje/kwf210
- Kark JD, Smith AH, Switzer BR, Hames CG. Serum vitamin a (retinol) and cancer incidence in Evans County, Georgia. J Natl Cancer Inst. 1981;66(1):7–16.
- Key TJ, Appleby PN, Travis RC, Albanes D, Alberg AJ, Barricarte A, Black A, Boeing H, Bueno-de-Mesquita HB, Chan JM, et al. Carotenoids, retinol, tocopherols, and prostate cancer risk: pooled analysis of 15 studies. Am J Clin Nutr. 2015;102(5):1142–57. doi:https://doi.org/10.3945/ajcn.115.114306
- Knekt P, Aromaa A, Maatela J, Aaran RK, Nikkari T, Hakama M, Hakulinen T, Peto R, Teppo L. Serum vitamin a and subsequent risk of cancer: cancer incidence follow-up of the finnish mobile clinic health examination survey. Am J Epidemiol. 1990;132(5):857–70. doi:https://doi.org/10.1093/oxfordjournals.aje.a115728
- Kristal AR, Till C, Platz EA, Song X, King IB, Neuhouser ML, Ambrosone CB, Thompson IM. Serum lycopene concentration and prostate cancer risk: results from the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev. 2011;20(4):638–46. doi:https://doi.org/10.1158/1055-9965.EPI-10-1221
- Mondul AM, Watters JL, Mannisto S, Weinstein SJ, Snyder K, Virtamo J, Albanes D. Serum retinol and risk of prostate cancer. Am J Epidemiol. 2011;173(7):813–21. doi:https://doi.org/10.1093/aje/kwq429
- Nash SH, Till C, Song X, Lucia MS, Parnes HL, Thompson IM, Jr., Lippman SM, Platz EA, Schenk J. Serum retinol and carotenoid concentrations and prostate cancer risk: results from the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev. 2015;24(10):1507–15. doi:https://doi.org/10.1158/1055-9965.EPI-15-0394
- Nomura AM, Stemmermann GN, Lee J, Craft NE. Serum micronutrients and prostate cancer in japanese americans in hawaii. Cancer Epidemiol Biomarkers Prev. 1997;6(7):487–91.
- Peleg I, Heyden S, Knowles M, Hames CG. Serum retinol and risk of subsequent cancer: extension of the Evans County, Georgia, study. J Natl Cancer Inst. 1984;73(6):1455–8.
- Reichman ME, Hayes RB, Ziegler RG, Schatzkin A, Taylor PR, Kahle LL, Fraumeni JF. Jr. Serum vitamin a and subsequent development of prostate cancer in the first national health and nutrition examination survey epidemiologic follow-up study. Cancer Res. 1990;50(8):2311–5.
- Schenk JM, Riboli E, Chatterjee N, Leitzmann MF, Ahn J, Albanes D, Reding DJ, Wang Y, Friesen MD, Hayes RB, et al. Serum retinol and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev. 2009;18(4):1227–31. doi:https://doi.org/10.1158/1055-9965.EPI-08-0984
- Willett WC, Polk BF, Underwood BA, Stampfer MJ, Pressel S, Rosner B, Taylor JO, Schneider K, Hames CG. Relation of serum vitamins a and e and carotenoids to the risk of cancer. N Engl J Med. 1984;310(7):430–4. doi:https://doi.org/10.1056/NEJM198402163100705
- Wang Y, Cui R, Xiao Y, Fang J, Xu Q. Effect of carotene and lycopene on the risk of prostate cancer: a systematic review and dose-response meta-analysis of observational studies. PLoS One. 2015;10(9):e0137427. doi:https://doi.org/10.1371/journal.pone.0137427
- Kaulmann A, Bohn T. Carotenoids, inflammation, and oxidative stress-implications of cellular signaling pathways and relation to chronic disease prevention. Nutr Res. 2014;34(11):907–29. doi:https://doi.org/10.1016/j.nutres.2014.07.010
- Miao B, X-D W. 2013. Provitamin A Carotenoids and Cancer Prevention. In: Sa T, editor. Carotenoids and Human Health. New York: Sringer Science + Business Media; pp. 181–192. .
- Dao DQ, Ngo TC, Thong NM, Nam PC. Is vitamin A an antioxidant or a pro-oxidant? J Phys Chem B. 2017;121(40):9348–57. doi:https://doi.org/10.1021/acs.jpcb.7b07065
- Tang XH, Gudas LJ. Retinoids, retinoic acid receptors, and cancer. Annu Rev Pathol. 2011;6:345–64. doi:https://doi.org/10.1146/annurev-pathol-011110-130303
- Uray IP, Dmitrovsky E, Brown PH. Retinoids and rexinoids in cancer prevention: from laboratory to clinic. Semin Oncol. 2016;43(1):49–64. doi:https://doi.org/10.1053/j.seminoncol.2015.09.002
- Alpha-Tocopherol B. The effect of vitamin e and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 1994;330(15):1029–35.
- Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL, Jr., Valanis B, Williams JH, Jr, et al. Risk factors for lung cancer and for intervention effects in caret, the beta-carotene and retinol efficacy trial. J Natl Cancer Inst. 1996;88(21):1550–9. doi:https://doi.org/10.1093/jnci/88.21.1550
- Key TJ, Appleby PN, Allen NE, Travis RC, Roddam AW, Jenab M, Egevad L, Tjonneland A, Johnsen NF, Overvad K, et al. Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European prospective investigation into cancer and nutrition study. Am J Clin Nutr. 2007;86(3):672–81. doi:https://doi.org/10.1093/ajcn/86.3.672
- Wu K, Erdman JW, Jr., Schwartz SJ, Platz EA, Leitzmann M, Clinton SK, DeGroff V, Willett WC, Giovannucci E. Plasma and dietary carotenoids, and the risk of prostate cancer: a nested case-control study. Cancer Epidemiol Biomarkers Prev. 2004;13(2):260–9. doi:https://doi.org/10.1158/1055-9965.EPI-03-0012
- De Marzo AM, Platz EA, Sutcliffe S, Xu J, Gronberg H, Drake CG, Nakai Y, Isaacs WB, Nelson WG. Inflammation in prostate carcinogenesis. Nat Rev Cancer. 2007;7(4):256–69. doi:https://doi.org/10.1038/nrc2090
- Platz EA, Kulac I, Barber JR, Drake CG, Joshu CE, Nelson WG, Lucia MS, Klein EA, Lippman SM, Parnes HL, et al. A prospective study of chronic inflammation in benign prostate tissue and risk of prostate cancer: linked pcpt and select cohorts. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the. Cancer Epidemiol Biomarkers Prev. 2017;26(10):1549–57. doi:https://doi.org/10.1158/1055-9965.EPI-17-0503
- Gurel B, Lucia MS, Thompson IM, Jr., Goodman PJ, Tangen CM, Kristal AR, Parnes HL, Hoque A, Lippman SM, Sutcliffe S, et al. Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev. 2014;23(5):847–56. doi:https://doi.org/10.1158/1055-9965.EPI-13-1126
- Debelo H, Novotny JA, Ferruzzi MG. Vitamin A. Adv Nutr. 2017;8(6):992–4. doi:https://doi.org/10.3945/an.116.014720
- Thompson IM, Goodman PJ, Tangen CM, Lucia MS, Miller GJ, Ford LG, Lieber MM, Cespedes RD, Atkins JN, Lippman SM, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med. 2003;349(3):215–24. doi:https://doi.org/10.1056/NEJMoa030660
- Goodman PJ, Tangen CM, Kristal AR, Thompson IM, Lucia MS, Platz EA, Figg WD, Hoque A, Hsing A, Neuhouser ML, et al. Transition of a clinical trial into translational research: the prostate cancer prevention trial experience. Cancer Prev Res (Phila). 2010;3(12):1523–33. doi:https://doi.org/10.1158/1940-6207.CAPR-09-0256
- Lietz G. 2013. Host Factors that Affect Carotenoid Metabolism. In: Tanumihardjo SA, editor. Carotenoids and Human Health. New York: Spinger Science + Business Media; pp. 129–140.
- Burri BJ. Beta-cryptoxanthin as a source of vitamin A. J Sci Food Agric. 2015;95(9):1786–94. doi:https://doi.org/10.1002/jsfa.6942
- Bae JM, Lee EJ, Guyatt G. Citrus fruits intake and prostate cancer risk: A quantitative systematic review. J Prev Med Public Health. 2008;41(3):159–64. doi:https://doi.org/10.3961/jpmph.2008.41.3.159
- Perez-Cornago A, Travis RC, Appleby PN, Tsilidis KK, Tjonneland A, Olsen A, Overvad K, Katzke V, Kuhn T, Trichopoulou A, et al. Fruit and vegetable intake and prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer. 2017;141(2):287–97. doi:https://doi.org/10.1002/ijc.30741
- Beydoun HA, Shroff MR, Mohan R, Beydoun MA. Associations of serum vitamin A and carotenoid levels with markers of prostate cancer detection among us men. Cancer Causes Control. 2011;22(11):1483–95. doi:https://doi.org/10.1007/s10552-011-9822-8